FDA Investigator Victor J Gangi
Victor J Gangi has conducted inspections on 19 sites in 6 countries as of 25 Oct 2000. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
19
Last Inspection Date:
25 Oct 2000
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Spain,
France,
United States of America,
Germany,
Italy,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Victor J Gangi:
Aimee Cunningham, PhD,
Amber G Wardwell,
Amy C Jordan,
Amy Devlin, PhD,
Andrew M Barlow,
Anissa M Cheung,
Arie C Menachem,
Ariel Cruz Figueroa,
Brenda P King,
Brentley S Collins,
Burnell M Henry,
Camerson E Moore,
Carl A Huffman, III,
Carla C Tuite,
CDR Thomas R Berry, PPh,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Cody D Rickman,
Constance Desimone,
Courtney N Long,
Darin S Wiegers,
David P Vanhouten,
Dawn M Braswell,
Debra J Bennett,
Diane Kelley,
Dr. Abhijit Raha, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Dr. Zhou Chen (nmi), MD PhD,
Ekaterina Allen,
Ellen P Madigan,
Erika V Butler,
Gary J Hagan,
Gene D Arcy,
Gunther Boekhoudt, PhD,
Hien Albright,
Ivis L Negron,
Jee Chung, PhD,
Joey V Quitania,
John P Mistler,
John S Hartford,
Jose Acruz Gonzalez,
Jose M Cayuela,
Jose R Hernandez,
Joyce A Rockwell,
Julie D Bringger,
Justine M Corson,
Kara A Scheibner, PhD,
Kathleen E Mcafoose,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kenneth G Klobus,
Kent A Conforti,
Kham Phommachanh,
Kristy A Zielny,
Laurie B Frazier,
LCDR Debra Emerson,
Leo B Zadecky,
Martha T Olone,
Martin J Guardia,
Mary Jeanet Mcgarry,
Marybet Lopez Negron,
Matthew B Casale,
Matthew C Watson,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Michael R Goga,
Michelle M Noe Varga,
Monique C Lo,
Mra Davism,
Mra Mcculloughj,
Nailing Zhang,
Norman Wong,
Ogechi C Nna,
Paraluman S Leonin,
Parul M Patel,
Patricia A Mcilroy,
Paul L Figarole, Jr,
Paula A Trost,
Philip Kreiter,
Prabhu P Raju,
Priscilla M Pastrana,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Richard W Thornton,
Robert J Martin,
Rory K Geyer,
Rosa J Motta,
Sean R Marcsisin,
Seth A Mailhot,
Stacey S Degarmo,
Stephen D Eich,
Susan M Jackson,
Susan O Oladeji,
Susanne M Richardson, MS RAC,
Tricia S Martinez,
Victoria M Daddeo,
Walter N Lange,
Wayne E Seifert,
Xiao Hong Chen,
Yanming An, PhD,
Yumi J Hiramine,
Zhong Li, PhD
Victor J Gangi's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more